EVALUER L'IMPACT PREDICTIF DU SCORE MEESSI POUR LA STRATIFICATION DU RISQUE DES PATIENTS ADMIS POUR INSUFFISANCE CARDIAQUE AIGUE DANS LES STRUCTURES D'URGENCES

Completed

• Conditions: Acurate Heart Failure
• Interventions: Other: MEESSI score

• Registration Number: NCT04417881
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Our primary purpose is to assess MEESSI score in predicting mortality and readmission of patients managed for acute heart failure (AHF) in Emergency Department.

European Society of Cardiology recommend risk stratification for patients with AHF. MEESSI score is not prospectively validated out of Spain.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-06-02
• Study First Submitted QC: 2020-06-02
• Study First Posted: 2020-06-05
• Study Start: 2020-12-19
• Primary Completion: 2020-12-19
• Study Completion: 2021-06-23
• Status Verified: 2021-10
• Last Update Submitted: 2021-10-01
• Last Update Posted: 2021-10-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 367

Inclusion Criteria

• Major patient
• Patient admitted to emergencies with suspicion of ICA according to the clinical intuition of the emergency doctor after interrogation, clinical examination, biology and imaging
• Patient with health insurance
• Subject who accept to participate in the research

Exclusion Criteria

• Patient who refuse to participate in the study
• Patient with coronary syndrome with ST segment elevation
• Other diagnosis of dyspnea
• Persons deprived of their freedom or under the protection of justice
• Persons under guardianship or curatorship
• Impossibility of giving the patient informed information
• Pregnant woman

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
patients with acurate heart failure	MEESSI score	-

Primary Outcome Measures

Name	Time	Method
MEESSI score	30 days	Tscore to predict the patient's future in the month following management for ED ICA. That is to say the number of days alive outside the hospital in the month following an ICA episode.

Secondary Outcome Measures

Name	Time	Method
Re-admission rate	30 days	30-day re-admission rate compared between the 4 risk categories defined by the MEESSI score
Mortality rate	30 days	Mortality rate at 30 days compared between the 4 risk categories defined by the MEESSI score
Sensitivity	30 days	Sensitivity, specificity and ROC curve of the MEESSI score in relation to the composite criterion according to the 4 risk categories

Trial Locations

Locations (14)

Hôpital Robert Pax; 🇫🇷 Sarreguemines, France

Les Hôpitaux Universitaires de Strasbourg; 🇫🇷 Strasbourg, France

CH Remiremont; 🇫🇷 Remiremont, France

CHU Pitié Salpetrière; 🇫🇷 Paris, France

CHU de Reims; 🇫🇷 Reims, France

CHU Toulouse; 🇫🇷 Toulouse, France

Centre Hospitalier Forez; 🇫🇷 Montbrison, France

Hôpital Jean Minjoz; 🇫🇷 Besançon, France

CH Haguenau; 🇫🇷 Haguenau, France

CHU de Nancy; 🇫🇷 Nancy, France

CHU de Montpellier; 🇫🇷 Montpellier, France

Centre Hospitalier Jean Rougié; 🇫🇷 Cahors, France

Hôpitaux Civils de Colmar; 🇫🇷 Colmar, France

Hôpital Nord Franche Comté; 🇫🇷 Trévenans, France